{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T16:06:44Z","timestamp":1777565204796,"version":"3.51.4"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"am","delay-in-days":338,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006733","name":"Indiana University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006733","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["T32MH103213-08"],"award-info":[{"award-number":["T32MH103213-08"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jpsychires.2025.02.065","type":"journal-article","created":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T16:27:07Z","timestamp":1740846427000},"page":"155-162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Psychiatric and racial\/ethnic differences in incident and long-term benzodiazepine use: A commercial healthcare claims study"],"prefix":"10.1016","volume":"184","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9231-3722","authenticated-orcid":false,"given":"Marianne G.","family":"Chirica","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3914-8235","authenticated-orcid":false,"given":"Sydney M.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6770-8762","authenticated-orcid":false,"given":"Patrick D.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Meraz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7010-7300","authenticated-orcid":false,"given":"Martin","family":"Rickert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8126-8177","authenticated-orcid":false,"given":"Anna","family":"Sidorchuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0114-4669","authenticated-orcid":false,"given":"Kurt","family":"Kroenke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5248-7434","authenticated-orcid":false,"given":"Brian M.","family":"D'Onofrio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jpsychires.2025.02.065_bib1","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.7399","article-title":"Patterns in outpatient benzodiazepine prescribing in the United States","volume":"2","author":"Agarwal","year":"2019","journal-title":"JAMA Netw. Open"},{"issue":"4","key":"10.1016\/j.jpsychires.2025.02.065_bib2","doi-asserted-by":"crossref","first-page":"E208","DOI":"10.9778\/cmajo.20130076","article-title":"Use of benzodiazepines and related drugs in Manitoba: a population-based study","volume":"2","author":"Alessi-Severini","year":"2014","journal-title":"CMAJ Open"},{"issue":"2","key":"10.1016\/j.jpsychires.2025.02.065_bib3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3109\/13651501.2012.667114","article-title":"Guidelines for the pharmacological treatment of anxiety disorders, obsessive\u2013compulsive disorder and posttraumatic stress disorder in primary care","volume":"16","author":"Bandelow","year":"2012","journal-title":"Int. J. Psychiatr. Clin. Pract."},{"issue":"5","key":"10.1016\/j.jpsychires.2025.02.065_bib4","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1176\/appi.ps.202000932","article-title":"Variation in psychotropic medication prescription for adults with schizophrenia in the United States","volume":"73","author":"Bareis","year":"2022","journal-title":"Psychiatr. Serv."},{"issue":"6","key":"10.1016\/j.jpsychires.2025.02.065_bib5","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.18m12174","article-title":"Prevalence and correlates of benzodiazepine use, misuse, and use disorders among adults in the United States","volume":"79","author":"Blanco","year":"2018","journal-title":"J. Clin. Psychiatry"},{"issue":"6","key":"10.1016\/j.jpsychires.2025.02.065_bib6","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/jgs.15292","article-title":"Benzodiazepine use in older adults in the United States, ontario, and Australia from 2010 to 2016","volume":"66","author":"Brett","year":"2018","journal-title":"J. Am. Geriatr. Soc."},{"issue":"5","key":"10.1016\/j.jpsychires.2025.02.065_bib7","doi-asserted-by":"crossref","first-page":"152","DOI":"10.18773\/austprescr.2015.055","article-title":"Management of benzodiazepine misuse and dependence","volume":"38","author":"Brett","year":"2015","journal-title":"Aust. Prescr."},{"issue":"10","key":"10.1016\/j.jpsychires.2025.02.065_bib8","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1176\/appi.ps.54.10.1395","article-title":"Benzodiazepine use and abuse among patients with severe mental illness and Co-occurring substance use disorders","volume":"54","author":"Brunette","year":"2003","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.jpsychires.2025.02.065_bib9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.drugalcdep.2018.02.011","article-title":"Examining racial\/ethnic differences in patterns of benzodiazepine prescription and misuse","volume":"187","author":"Cook","year":"2018","journal-title":"Drug Alcohol Depend."},{"issue":"4","key":"10.1016\/j.jpsychires.2025.02.065_bib10","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1177\/02698811211069096","article-title":"Comparative safety of chronic versus intermittent benzodiazepine prescribing in older adults: a population-based cohort study","volume":"36","author":"Davies","year":"2022","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.jpsychires.2025.02.065_bib11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.eurpsy.2011.11.003","article-title":"Do benzodiazepines still deserve a major role in the treatment of psychiatric disorders? A critical reappraisal","volume":"28","author":"Dell\u2019osso","year":"2013","journal-title":"Eur. Psychiatry"},{"issue":"3","key":"10.1016\/j.jpsychires.2025.02.065_bib12","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4088\/PCC.v10n0307","article-title":"Combination treatment with benzodiazepines and SSRIs for comorbid anxiety and depression: a review","volume":"10","author":"Dunlop","year":"2008","journal-title":"Prim. Care Companion J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.jpsychires.2025.02.065_bib13","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3390\/neurolint13040059","article-title":"Benzodiazepines: uses, dangers, and clinical considerations","volume":"13","author":"Edinoff","year":"2021","journal-title":"Neurol. Int."},{"issue":"7","key":"10.1016\/j.jpsychires.2025.02.065_bib14","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1532-5415.2000.tb04758.x","article-title":"Long-term continuous use of benzodiazepines by older adults in quebec: prevalence, incidence and risk factors","volume":"48","author":"Egan","year":"2000","journal-title":"J. Am. Geriatr. Soc."},{"issue":"1","key":"10.1016\/j.jpsychires.2025.02.065_bib15","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.drugalcdep.2009.04.017","article-title":"Predictors of the incidence and discontinuation of long-term use of benzodiazepines: a population-based study","volume":"104","author":"Fang","year":"2009","journal-title":"Drug Alcohol Depend."},{"issue":"5","key":"10.1016\/j.jpsychires.2025.02.065_bib16","doi-asserted-by":"crossref","first-page":"E661","DOI":"10.4088\/JCP.15m10271","article-title":"Benzodiazepine use and risk of mortality among patients with schizophrenia: a retrospective longitudinal study","volume":"77","author":"Fontanella","year":"2016","journal-title":"J. Clin. Psychiatr."},{"issue":"9","key":"10.1016\/j.jpsychires.2025.02.065_bib17","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1007\/s11606-019-05098-0","article-title":"Discontinuation of chronic benzodiazepine use among adults in the United States","volume":"34","author":"Gerlach","year":"2019","journal-title":"J. Gen. Intern. Med."},{"issue":"2","key":"10.1016\/j.jpsychires.2025.02.065_bib18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/jcm7020017","article-title":"Benzodiazepines I: upping the care on downers: the evidence of risks, benefits and alternatives","volume":"7","author":"Guina","year":"2018","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.jpsychires.2025.02.065_bib19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2217\/nmt-2020-0056","article-title":"Benzodiazepine use among older adults","volume":"11","author":"Gupta","year":"2021","journal-title":"Neurodegener. Dis. Manag."},{"key":"10.1016\/j.jpsychires.2025.02.065_bib20","first-page":"1","article-title":"Issues in developing a surveillance case definition for nonfatal suicide attempt and intentional self-harm using International Classification of Diseases, Tenth Revision, Clinical Modification (ICD\u201310\u2013CM) coded data","volume":"108","author":"Hedegaard","year":"2018","journal-title":"National Health Statistics reports"},{"issue":"5","key":"10.1016\/j.jpsychires.2025.02.065_bib21","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1007\/s11606-020-06339-3","article-title":"Validity of incident opioid use disorder (OUD) diagnoses in administrative data: a chart verification study","volume":"36","author":"Howell","year":"2021","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.jpsychires.2025.02.065_bib22","doi-asserted-by":"crossref","DOI":"10.1007\/s00228-023-03515-2","article-title":"Factors associated with long-term benzodiazepine and Z-drug use across the lifespan and 5-year temporal trajectories among incident users: a Swedish nationwide register-based study","author":"Isomura","year":"2023","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.jpsychires.2025.02.065_bib23","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jsat.2019.10.001","article-title":"Factors associated with benzodiazepine prescribing in community mental health settings","volume":"109","author":"Jessell","year":"2020","journal-title":"J. Subst. Abuse Treat."},{"issue":"4","key":"10.1016\/j.jpsychires.2025.02.065_bib24","first-page":"224","article-title":"Risks associated with long-term benzodiazepine use","volume":"88","author":"Johnson","year":"2013","journal-title":"Am. Fam. Physician"},{"issue":"647","key":"10.1016\/j.jpsychires.2025.02.065_bib25","doi-asserted-by":"crossref","first-page":"e410","DOI":"10.3399\/bjgp16X685213","article-title":"Benzodiazepine and z-hypnotic prescribing for older people in primary care: a cross-sectional population-based study","volume":"66","author":"Johnson","year":"2016","journal-title":"Br. J. Gen. Pract."},{"issue":"3","key":"10.1016\/j.jpsychires.2025.02.065_bib26","doi-asserted-by":"crossref","first-page":"337","DOI":"10.31887\/DCNS.2015.17.3\/akaczkurkin","article-title":"Cognitive-behavioral therapy for anxiety disorders: an update on the empirical evidence","volume":"17","author":"Kaczkurkin","year":"2015","journal-title":"Dialogues Clin. Neurosci."},{"issue":"2","key":"10.1016\/j.jpsychires.2025.02.065_bib27","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1176\/appi.ps.201700095","article-title":"Long-term use of benzodiazepines and nonbenzodiazepine hypnotics, 1999\u20132014","volume":"69","author":"Kaufmann","year":"2018","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.jpsychires.2025.02.065_bib28","series-title":"Data Source: the American Community Survey, Health Insurance Coverage of the Total Population for 2023","article-title":"State health facts","year":"2023"},{"issue":"1","key":"10.1016\/j.jpsychires.2025.02.065_bib29","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1176\/appi.ps.202100671","article-title":"Walking the benzodiazepine high wire","volume":"74","author":"Kroenke","year":"2023","journal-title":"Psychiatr. Serv."},{"issue":"8","key":"10.1016\/j.jpsychires.2025.02.065_bib30","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.eurpsy.2015.09.003","article-title":"Long-term use of benzodiazepines: definitions, prevalence and usage patterns - a systematic review of register-based studies","volume":"30","author":"Kurko","year":"2015","journal-title":"Eur. Psychiatry"},{"issue":"6","key":"10.1016\/j.jpsychires.2025.02.065_bib31","first-page":"561","article-title":"Incidence and characteristics of benzodiazepine use in an elderly cohort: the EVA study","volume":"60","author":"Lechevallier-Michel","year":"2005","journal-title":"Therapie (Paris)"},{"issue":"1","key":"10.1016\/j.jpsychires.2025.02.065_bib32","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s40264-020-00992-7","article-title":"Patterns of benzodiazepine use and excess risk of all-cause mortality in the elderly: a nationwide cohort study","volume":"44","author":"Mathieu","year":"2021","journal-title":"Drug Saf."},{"issue":"2","key":"10.1016\/j.jpsychires.2025.02.065_bib33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1176\/appi.ps.201800321","article-title":"Benzodiazepine use and misuse among adults in the United States","volume":"70","author":"Maust","year":"2019","journal-title":"Psychiatr. Serv."},{"issue":"5","key":"10.1016\/j.jpsychires.2025.02.065_bib34","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.addbeh.2014.01.009","article-title":"Medical and nonmedical use of prescription benzodiazepine anxiolytics among U.S. high school seniors","volume":"39","author":"McCabe","year":"2014","journal-title":"Addict. Behav."},{"issue":"4","key":"10.1016\/j.jpsychires.2025.02.065_bib35","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1055\/s-2007-979558","article-title":"Long-term use of benzodiazepines: tolerance, dependence and clinical problems in anxiety and mood disorders","volume":"29","author":"Michelini","year":"1996","journal-title":"Pharmacopsychiatry"},{"issue":"4","key":"10.1016\/j.jpsychires.2025.02.065_bib36","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/amiajnl-2011-000116","article-title":"Normalized names for clinical drugs: RxNorm at 6 years","volume":"18","author":"Nelson","year":"2011","journal-title":"J. Am. Med. Inf. Assoc."},{"issue":"3","key":"10.1016\/j.jpsychires.2025.02.065_bib37","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/09540260500071863","article-title":"The epidemiology of long-term benzodiazepine use","volume":"17","author":"Neutel","year":"2005","journal-title":"Int. Rev. Psychiatr."},{"issue":"2","key":"10.1016\/j.jpsychires.2025.02.065_bib38","first-page":"91","article-title":"Combined pharmacotherapy and cognitive-behavioral therapy for anxiety disorders: medication effects, glucocorticoids, and attenuated treatment outcomes","volume":"17","author":"Otto","year":"2010","journal-title":"Clin. Psychol."},{"issue":"1","key":"10.1016\/j.jpsychires.2025.02.065_bib39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00406-018-0966-3","article-title":"Use of benzodiazepines and z-drugs not compliant with guidelines and associated factors: a population-based study","volume":"270","author":"Panes","year":"2020","journal-title":"Eur. Arch. Psychiatr. Clin. Neurosci."},{"issue":"3","key":"10.1016\/j.jpsychires.2025.02.065_bib40","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/bcp.14165","article-title":"Misuse of benzodiazepines: prevalence and impact in an inpatient population with psychiatric disorders","volume":"86","author":"Panes","year":"2020","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.jpsychires.2025.02.065_bib41","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1001\/archinte.166.5.572","article-title":"Racial disparities in access after regulatory surveillance of benzodiazepines","volume":"166","author":"Pearson","year":"2006","journal-title":"Arch. Intern. Med."},{"issue":"6","key":"10.1016\/j.jpsychires.2025.02.065_bib42","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.genhosppsych.2015.06.004","article-title":"Demographic and clinical factors associated with benzodiazepine prescription at discharge from psychiatric inpatient treatment","volume":"37","author":"Peters","year":"2015","journal-title":"Gen. Hosp. Psychiatry"},{"issue":"1","key":"10.1016\/j.jpsychires.2025.02.065_bib43","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/j.pain.0000000000000730","article-title":"Incident and long-term opioid therapy among patients with psychiatric conditions and medications: a national study of commercial health care claims","volume":"158","author":"Quinn","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.jpsychires.2025.02.065_bib44","article-title":"Racial-ethnic disparities in benzodiazepine prescriptions for anxiety in US emergency departments","author":"Ribas Roca","year":"2022","journal-title":"J Racial Ethn Health Disparities"},{"key":"10.1016\/j.jpsychires.2025.02.065_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100741","article-title":"Fatal self-injury in the United States, 1999\u20132018: unmasking a national mental health crisis","volume":"32","author":"Rockett","year":"2021","journal-title":"EClinicalMedicine"},{"issue":"3","key":"10.1016\/j.jpsychires.2025.02.065_bib46","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1176\/appi.ajp.20230075","article-title":"Long-term use of benzodiazepines and benzodiazepine-related drugs: a register-based Danish cohort study on determinants and risk of dose escalation","volume":"181","author":"Rosenqvist","year":"2024","journal-title":"Am. J. Psychiatr."},{"issue":"1","key":"10.1016\/j.jpsychires.2025.02.065_bib47","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s12603-011-0015-7","article-title":"Association between benzodiazepines and recurrent falls: a cross-sectional elderly population-based study","volume":"15","author":"Rossat","year":"2011","journal-title":"J. Nutr. Health Aging"},{"key":"10.1016\/j.jpsychires.2025.02.065_bib49","series-title":"SAS\/ACCESS\u00ae 9.4 Interface to ADABAS","year":"2013"},{"issue":"9","key":"10.1016\/j.jpsychires.2025.02.065_bib50","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-030858","article-title":"Characterisation of concurrent use of prescription opioids and benzodiazepine\/Z-drugs in Alberta, Canada: a population-based study","volume":"9","author":"Sharma","year":"2019","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.jpsychires.2025.02.065_bib51","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.0321","article-title":"Racial disparities in diagnosis of attention-deficit\/hyperactivity disorder in a US national birth cohort","volume":"4","author":"Shi","year":"2021","journal-title":"JAMA Netw. Open"},{"issue":"5","key":"10.1016\/j.jpsychires.2025.02.065_bib52","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/YIC.0000000000000276","article-title":"Effectiveness and safety of long-term benzodiazepine use in anxiety disorders: a systematic review and meta-analysis","volume":"34","author":"Shinfuku","year":"2019","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.jpsychires.2025.02.065_bib53","doi-asserted-by":"crossref","first-page":"593","DOI":"10.18203\/2319-2003.ijbcp20161496","article-title":"Treatment options for the specific phobias","volume":"5","author":"Singh","year":"2016","journal-title":"Int. J. Basic Clin. Pharmacol."},{"issue":"10","key":"10.1016\/j.jpsychires.2025.02.065_bib54","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.19029","article-title":"Incidence of and characteristics associated with long-term benzodiazepine use in Finland","volume":"3","author":"Taipale","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"7","key":"10.1016\/j.jpsychires.2025.02.065_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2018.e00688","article-title":"Patterns of benzodiazepines use in primary care adults with anxiety disorders","volume":"4","author":"Tanguay Bernard","year":"2018","journal-title":"Heliyon"},{"issue":"11","key":"10.1016\/j.jpsychires.2025.02.065_bib56","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1176\/appi.ps.202100617","article-title":"Long-term benzodiazepine use and discontinuation among patients in the U.S. Veterans health administration","volume":"73","author":"Timko","year":"2022","journal-title":"Psychiatr. Serv."},{"issue":"10","key":"10.1016\/j.jpsychires.2025.02.065_bib57","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1176\/appi.ps.201900446","article-title":"Concurrent opioid and benzodiazepine utilization patterns and predictors among community-dwelling adults in the United States","volume":"71","author":"Vadiei","year":"2020","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.jpsychires.2025.02.065_bib58","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2022.2733","article-title":"Characterizing and coding psychiatric diagnoses using electronic health record data","author":"Wright","year":"2022","journal-title":"JAMA Psychiatry"},{"issue":"10","key":"10.1016\/j.jpsychires.2025.02.065_bib59","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.3390\/jpm13101485","article-title":"Benzodiazepine use and the risk of dementia in the elderly population: an umbrella review of meta-analyses","volume":"13","author":"Wu","year":"2023","journal-title":"J. Personalized Med."},{"issue":"8","key":"10.1016\/j.jpsychires.2025.02.065_bib60","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1176\/ps.62.8.pss6208_0908","article-title":"Benzodiazepine use among patients with schizophrenia in taiwan: a nationwide population-based survey","volume":"62","author":"Wu","year":"2011","journal-title":"Psychiatr. Serv."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002239562500144X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002239562500144X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T15:15:42Z","timestamp":1751382942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002239562500144X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":59,"alternative-id":["S002239562500144X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2025.02.065","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psychiatric and racial\/ethnic differences in incident and long-term benzodiazepine use: A commercial healthcare claims study","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2025.02.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}